Open access
9,261
Views
11
CrossRef citations to date
0
Altmetric
Review
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties
Hristo L. Svilenova Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Gent, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0001-5863-9569View further author information
, https://orcid.org/0000-0001-5863-9569View further author information
Paolo Arosiob Department of Chemistry and Applied Biosciences, ETH Zürich, Zürich, SwitzerlandView further author information
, Tim Menzenc Coriolis Pharma Research GmbH, Martinsried, 82152, GermanyView further author information
, Peter Tessierd Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, USA;e Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA;f Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA;g Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USAView further author information
& Pietro Sormannih Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UKView further author information
Article: 2164459
|
Received 15 Nov 2022, Accepted 29 Dec 2022, Published online: 11 Jan 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.